BIRC5 and cancer: Survivin has been proposed as a promising tumour biomarker mainly due to work using serial analysis of gene expression (SAGE), which revealed that survivin was the fourth most highly expressed transcript in a number of common cancers, but was rarely present in normal terminally-differentiated tissues [3].